SCHEMBL26077367

SCHEMBL26077367

CC1CCN(c2ccc(OCc3ccccc3)cn2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
LMNA P02545 4/20 0.54
MAPT P10636 3/20 0.54
NPC1 O15118 3/20 0.54
RAB9A P51151 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
TSHR P16473 2/20 0.54
KDM4E B2RXH2 3/20 0.53
MCHR1 Q99705 1/20 0.49
HTT P42858 2/20 0.49
OGA O60502 1/20 0.47
PRMT5 O14744 2/20 0.47
NTRK1 P04629 1/20 0.47
HRH3 Q9Y5N1 2/20 0.46
P4HTM Q9NXG6 1/20 0.46
DGAT1 O75907 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
CHRM4 P08173 1/20 0.45
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26077251 0.86 KIT (0.53) ALDH1A1LMNAKDM4EHRH3P4HTM
SCHEMBL25173787 0.86 DGAT1 (0.50) ALDH1A1LMNAMAPTNPC1RAB9A
SCHEMBL30913560 0.86 DGAT1 (0.50) ALDH1A1LMNAMAPTNPC1RAB9A
SCHEMBL20425289 0.85 MCHR1 (0.45) ALDH1A1LMNAMAPTNPC1RAB9A
SCHEMBL25176689 0.85 MCHR1 (0.48) ALDH1A1LMNAMAPTNPC1RAB9A
SCHEMBL30913568 0.85 MCHR1 (0.48) ALDH1A1LMNAMAPTNPC1RAB9A
SCHEMBL11956908 0.85 RAB9A (0.52) ALDH1A1LMNAMAPTNPC1RAB9A
SCHEMBL25170721 0.83 MCHR1 (0.45) ALDH1A1LMNAMAPTNPC1RAB9A
SCHEMBL2309052 0.82 NTRK1 (0.64) MAPTNPC1RAB9AHTTPRMT5
SCHEMBL31104885 0.82 PRMT5 (0.57) ALDH1A1MAPTNPC1RAB9ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11773078-B2 Furin inhibitors GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2023-10-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11773078-B2 Furin inhibitors FURIN, TGFB1, PCSK7 ALDH1A1 3733/4885LMNA 264/4885MAPT 3082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.